Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors - Takeaways - MDSpire

Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors

  • By

  • Iqra Ajmal

  • Bingtan Du

  • Na Huang

  • Qianying Huang

  • Dan Jiang

  • Muhammad Asad Farooq

  • Guangxian Xu

  • May 20, 2026

  • 0 min

Share

  • 1

    CAR-T cell therapy has transformed hematologic cancer treatment but faces challenges like severe toxicities and poor solid tumor infiltration.

  • 2

    Recent genetic engineering strategies aim to enhance CAR-T safety, durability, and efficacy through various innovative approaches.

  • 3

    Affinity-tuned scFvs, hinge/TM optimization, and programmable switch systems have been developed to mitigate treatment-related toxicities.

  • 4

    TME remodeling techniques, including nanomaterials and engineered viruses, are being explored to improve CAR-T cell effectiveness in solid tumors.

  • 5

    Integrated, patient-specific CAR-T platforms are emerging, focusing on safety controls and enhanced trafficking to broaden clinical applications.

Original Source(s)

Advanced strategies to enhance the safety, persistence, and efficacy of CAR-T cells in solid tumors

  • by Iqra Ajmal, Bingtan Du, Na Huang, Qianying Huang, Dan Jiang, Muhammad Asad Farooq, Guangxian Xu

  • May 20, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features